| Product NDC: | 0004-0186 | 
| Proprietary Name: | Boniva | 
| Non Proprietary Name: | ibandronate sodium | 
| Active Ingredient(s): | 150 mg/1 & nbsp; ibandronate sodium | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, FILM COATED | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0004-0186 | 
| Labeler Name: | Genentech, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA021455 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20020715 | 
| Package NDC: | 0004-0186-82 | 
| Package Description: | 3 BLISTER PACK in 1 BOX (0004-0186-82) > 1 TABLET, FILM COATED in 1 BLISTER PACK | 
| NDC Code | 0004-0186-82 | 
| Proprietary Name | Boniva | 
| Package Description | 3 BLISTER PACK in 1 BOX (0004-0186-82) > 1 TABLET, FILM COATED in 1 BLISTER PACK | 
| Product NDC | 0004-0186 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | ibandronate sodium | 
| Dosage Form Name | TABLET, FILM COATED | 
| Route Name | ORAL | 
| Start Marketing Date | 20020715 | 
| Marketing Category Name | NDA | 
| Labeler Name | Genentech, Inc. | 
| Substance Name | IBANDRONATE SODIUM | 
| Strength Number | 150 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |